Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier, Walter Prof. Dr. (1) Dahlmann, Mathias Dr. (2) Kobelt, Dennis Dr. (2) Mathas, Stephan Dr. (8) Schlag, Peter M. Prof. Dr. (33) Schmitt, Clemens Prof. Dr. (1) Smith, Janice (3) Specker, Edgar Dr. (2) Stein, Ulrike Prof. Dr. (19) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (18) Wollert-Wulf, Brigitte (2) (-) Daniel, Peter Prof. Dr. (3) (-) Janz, Martin Dr. (7) (-) Lusatis, Simone (1) Bioinformatics and Omics Data Science (1) Bioinformatik der Genregulation (2) (-) Biologie maligner Lymphome (7) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Nicht-Kodierende RNAs und Mechanismen der Genregulation im Cytoplasma (2) Proteom Dynamik (8) RNA Biologie und Posttranscriptionale Regulation (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) Systems Biology Imaging (1) (-) Translationale Onkologie solider Tumore (9) 1992 (2) 1993 (1) 1994 (1) 1996 (1) 1997 (1) 1998 (1) 1999 (1) (-) 2000 (1) 2001 (3) 2002 (2) 2003 (8) 2004 (3) 2005 (4) (-) 2006 (11) 2007 (3) 2008 (7) 2009 (8) 2010 (3) 2011 (9) 2012 (5) 2013 (4) 2014 (2) 2015 (4) 2016 (2) (-) 2017 (4) 2018 (2) 2019 (1) 2020 (5) 2021 (5) 2022 (4) 2023 (6) 2024 (1) 16 Ergebnisse: Active Filter: Daniel, Peter Prof. Dr.Janz, Martin Dr.Lusatis, SimoneBiologie maligner LymphomeTranslationale Onkologie solider Tumore200020062017 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 10. Januar 2006 / J Clin Oncol Vascular endothelial growth factor-D and its receptor VEGFR-3: Two novel independent prognostic markers in gastric adenocarcinoma S. Juettner C. Wissmann T. Joens M. Vieth J. Hertel S. Gretschel P.M. Schlag W. Kemmner M. Hoecker 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. Januar 2006 / Nat Methods Laser microdissection of a colon cancer specimen with subsequent RNA isolation, mRNA amplification and microarray hybridization E. Stoinski-Bungs S. Seeger W. Kemmner P. Scheinert G. Krupp 01. März 2000 / Gut Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases T. Petretti W. Kemmner B. Schulze P.M. Schlag 01. Oktober 2006 / Am J Pathol H-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signaling I. Nazarenko G. Kristiansen S. Fonfara R. Guenther C. Gieseler W. Kemmner R. Schaefer I. Petersen C. Sers 01. Dezember 2006 / Chirurg Minimalresiduale Tumorerkrankung bei gastrointestinalen Karzinomen : Prognoserelevanz und onkologisch-chirurgische Konsequenzen [Minimal residual tumor in gastrointestinal carcinoma: Relevance to prognosis and oncologic surgical consequences] S. Gretschel A. Bembenek T. Schulze W. Kemmner P.M. Schlag 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 10. Mai 2006 / BMC Cancer Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy I. Sturm B. Rau P.M. Schlag P. Wust B. Hildebrandt H. Riess S. Hauptmann B. Doerken P.T. Daniel Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
10. Januar 2006 / J Clin Oncol Vascular endothelial growth factor-D and its receptor VEGFR-3: Two novel independent prognostic markers in gastric adenocarcinoma S. Juettner C. Wissmann T. Joens M. Vieth J. Hertel S. Gretschel P.M. Schlag W. Kemmner M. Hoecker
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. Januar 2006 / Nat Methods Laser microdissection of a colon cancer specimen with subsequent RNA isolation, mRNA amplification and microarray hybridization E. Stoinski-Bungs S. Seeger W. Kemmner P. Scheinert G. Krupp
01. März 2000 / Gut Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases T. Petretti W. Kemmner B. Schulze P.M. Schlag
01. Oktober 2006 / Am J Pathol H-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signaling I. Nazarenko G. Kristiansen S. Fonfara R. Guenther C. Gieseler W. Kemmner R. Schaefer I. Petersen C. Sers
01. Dezember 2006 / Chirurg Minimalresiduale Tumorerkrankung bei gastrointestinalen Karzinomen : Prognoserelevanz und onkologisch-chirurgische Konsequenzen [Minimal residual tumor in gastrointestinal carcinoma: Relevance to prognosis and oncologic surgical consequences] S. Gretschel A. Bembenek T. Schulze W. Kemmner P.M. Schlag
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
10. Mai 2006 / BMC Cancer Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy I. Sturm B. Rau P.M. Schlag P. Wust B. Hildebrandt H. Riess S. Hauptmann B. Doerken P.T. Daniel